Studies genes in people with inflammatory bowel disease
Collects tissue samples to study genes in people with inflammatory bowel disease.
Plain-language title generated from the registry record
Registry title: Gene Expression in Inflammatory Bowel Disease
Key facts
- Where
- Baltimore, United StatesSee the site
Where in United States
- Johns Hopkins University School Of MedicineBaltimore, United StatesNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Johns Hopkins University
- Trial code
- NCT01171872
- Record updated
- 16 January 2026
- Original description
Inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), is a idiopathic, chronic and frequently disabling inflammatory disorder of the intestines characterized by a dysregulated mucosal immune response that affect more than a million Americans. This protocol is aimed at obtaining tissue samples to test for expression of genes associated with IBD and to better understand the pathogenesis of IBD with the study of genetics, proteomics, physiologic processes and microbiomes (microbiology).Read full original descriptionShow less
Gene Expression in Inflammatory Bowel Disease
Inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), is a idiopathic, chronic and frequently disabling inflammatory disorder of the intestines characterized by a dysregulated mucosal immune response that affect more than a million Americans. This protocol is aimed at obtaining tissue samples to test for expression of genes associated with IBD and to better understand the pathogenesis of IBD with the study of genetics, proteomics, physiologic processes and microbiomes (microbiology).
Inclusion: All persons, regardless of IBD affection status, greater than 7 years of age undergoing upper or lower endoscopy or bowel resection.
Exclusion: Persons on anti-coagulation therapy or who will be place on anti-coagulation therapy following the planned endoscopy procedures; Persons with bleeding tendencies.